Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397744 · ClinicalTrials.gov registry record · NA
Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El Paso
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 660
- Enrollment target
NCT04397744: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT04397744 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 660 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04397744, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
Study Summary
The purpose of this study is to develop, implement and evaluate a comprehensive breast and cervical cancer screening program designed to increase uptake of breast and cervical cancer screening among rarely and never-screened low-income women in El Paso County and to increase repeat screening among those currently overdue.
Interventions
- BEHAVIORAL Unidas por Vida y Salud prevention program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2015-01-16 |
| Est. Completion | 2017-10-17 |
| Phase | NA |
What the finished NCT04397744 record still lists
NCT04397744 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Unidas por Vida y Salud prevention program is the first listed.
NCT04397744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04397744 about?
NCT04397744 is a clinical study titled "Unidas Por Vida y Salud: Increasing Breast and Cervical Cancer Screening in El Paso". The purpose of this study is to develop, implement and evaluate a comprehensive breast and cervical cancer screening program designed to increase uptake of breast and cervical cancer screening among rarely and never-screened low-income women in El Paso County and to increase repeat screening among t...
What is the current status of trial NCT04397744?
This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2015-01-16. Estimated completion is 2017-10-17.
What interventions are being tested in trial NCT04397744?
The interventions under investigation include: Unidas por Vida y Salud prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04397744?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04397744's enrollment target sits among peer trials
660 155th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI